Agree.
FDA is expected to inspect the Lonza Singapore, Tuas site as part of the Rem-L BLA review for aGvHD.
In the conference call today Dr Itescu informed shareholders that they have just completed last week (in preparation for the expected FDA inspection review) a successful mock pre-approval inspection of GMP manufacturing facility and our processes; and this mock inspection compromised both on site and virtual inspection by independent auditors.
Promising signs.
Agree. FDA is expected to inspect the Lonza Singapore, Tuas site...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 98.0¢ | $4.720M | 4.751M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 171759 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 16000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |